Document Actions
Lily Wu, Ph.D.
Research Professor of Pathology
Scholarly Emphasis:
Cholesterol, lipoprotein and coronary heart disease.
Titles:
- Research Professor, Pathology Department
- Medical Director, ARUP
- Director, Cardiovacular Genetic Research, Biochemistry Laboratory
About Lily Wu, Ph.D.
In the Cardiovascular Genetic Research Clinic Dr. Wu has been instrumental in developing a quality CDC standardized lipid laboratory. The key function of the laboratory is to provide lipid, lipoprotein, and LDL tests and to assess risk factors relating to hypertension and coronary diseases. As Director of ARUP's Reagent Production Laboratory she oversees the preparation of in-house test kits, an integral part of patient care service.
Selected Publications
- 1. Hopkins PN, Wu LL, Hunt SC, Brinton EA. (Apr 2005). Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease. J Am Coll Cardiol, 45(7), 1003-12.
- 2. Hunt SC, Xin Y, Wu LL, Hopkins PN, and Adams TD. (2006). Lack of association of glutamate decarboxylase 2 gene polymorphisms with severe obesity in Utah. Obesity, (14), 650-5.
- 3. Hunt SC, Xin Y, Wu LL, Cawthon RM, Coon H, Hasstedt SJ, and Hopkins PN. (Mar 2006). Sodium bicarbonate cotransporter polymorphisms are associated with baseline and 10-year follow-up blood pressures. Hypertension, 47(3), 532-6.
- 4. Wu JT, Wu LL. (Apr 2006). Linking inflammation and atherogenesis: Soluble markers identified for the detection of risk factors and for early risk assessment. Clin Chim Acta, 366((1-2)), 74-80.
- 5. Hunt SC, Xin Y, Wu LL, Hopkins PN, and Adams TD. (April 14, 2006). Lack of association of glutamate decarboxylase 2 gene polymorphisms with severe obesity in Utah. Obesity, 14(4), 650-5.
- 6. Chang PY, Wu TL, Hung CC, Tsao KC, Sun CF, Wu LL, and Wu JT. (2006). Development of an ELISA for myeloperoxidase on microplate: Normal reference values and effect of temperature on specimen preparation. Clinica Chimica Acta, 373, 158-163.
- 7. Wu TL, I Chen Tsai, Chang PY, Tsao KC, Sun CF, Wu LL, and Wu JT. (2006). Establishment of an in-house ELISA and the reference range for serum amyloid A (SAA) Complementary between SAA and C-reactive protein as markers of inflammation. Clinica Chimica Acta, 376, 72-76.
- 8. Wu T-L, Chang P-Y, Tsao K-C, Sun C-F, Wu LL, Wu JT. (2007). A panel of multiple markers associated with chronic systemic inflammation and the risk of atherogenesis is detectable in asthma and COPD. J Clin Lab Anal, 21, 1-5.
- 9. Wu, JT, Wu LL. (2007). Chronic systemic inflammation leading eventually to myocardial infarction, stroke, COPD, renal failure and cancer is induced by multiple risk factors. J Biomed Sci, 19, 1-6.
- 10. Sun YC, Chang PY, Tsao KC, Wu TL, Sun CF, Wu LL, Wu JT. (2007). Establishment of a sandwich ELISA using commercial antibody for plasma or serum 3-nitrotyrosine (3NT). Elevation in inflammatory diseases and complementary between 3NT and myeloperoxidase. Clinica Chimica Acta, 378, 175-180.
- All Publications: Click Here
Professional Education
- B.S. National Taiwan University (Biochemistry)
- University of California Graduate School (Nutrition) Davis, CA
- M.S. Oregon State University (Biochemistry) Corvallis, OR
- Ph.D. University of Utah School of Medicine (Biochemistry) Salt Lake City, UT
- Ph.D. University of Utah (Biology) Salt Lake City, UT
- Certificate Smith College (Molecular Biology)
- FELLOW University of Utah (Clinical Chemistry) Salt Lake City, UT